Reactive astrocytes release GFAP-positive extracellular vesicles (Astrocyte-EVs) into circulation with end-feet retraction from blood vessels. These vesicles specifically originate from brain astrocytes (marked by CNS-specific proteins like GFAP and GLAST) and reflect early astrocyte dysfunction preceding BBB breakdown. Quantification of brain-derived Astro-EVs provides a highly specific biomarker if source attribution can be validated.
Curated pathway from expert analysis
flowchart TD A["Neuroinflammatory Stimulus"] --> B["Reactive Astrocyte Transformation"] B --> C["GFAP Upregulation in Astrocytes"] C --> D["End-feet Retraction from Blood Vessels"] D --> E["GFAP-positive Astro-EV Release"] E --> F["CNS-specific Markers on EVs"] F --> G["EVs Enter Peripheral Circulation"] G --> H["Brain-derived Astro-EV Quantification"] H --> I["Early Neuroinflammation Detection"] H --> J["BBB Dysfunction Monitoring"] I --> K["AD Pathology Risk Assessment"] J --> K
No linked papers recorded for this hypothesis yet.
Median TPM across 13 brain regions for GFAP (Glial Fibrillary Acidic Protein) on brain-derived EVs from GTEx v10.
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for GFAP (Glial Fibrillary Acidic Protein) on brain-derived EVs.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| If GFAP-bearing brain-derived EVs (GFAP+ events) reflect reactive astrocytosis and predict neurodegeneration progression, then elevated GFAP+ EV counts will correlate with astrocyte reactivity markers | In AD/MCI cohort (n≥100), high GFAP+ EV count at baseline correlates with CSF GFAP (r>0.5), predicts MMSE decline rate >2x faster and hippocampal atrophy rate > | — no observation — | pending | 0.72 |